Home Patheon

Patheon

acquired
IPO Delisting
Drug Developer
Basic
Enterprise Profile

Basic Information

Patheon Inc. provides commercial manufacturing and drug development services to the global pharmaceutical and biotechnology industries. Its commercial manufacturing activities primarily involve prescription and over-the-counter products in solid, semi-solid, liquid, and sterile dosage forms. The company also offers a range of specialized drug development capabilities, including high-potency, sterile, lyophilized, and controlled-release formulations. Patheon delivers products to approximately 120 countries and provides a comprehensive suite of services, including manufacturing, logistics, and packaging for conventional dosage forms, sterile dosage forms, and specialty products.
Patheon, Inc.
NorthCarolina,United States of America
more than 500 people
January 01, 1974
doingbusiness@patheon.com

Enterprise Profile

Industrial Sector
New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Gene Technology Biotechnology
Concept
Therapeutic Products Department of Pharmacy
Application Scenarios
Innovative Drugs Prescription Drug Over-the-Counter Drugs